Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J J ; Barrios, C H ; Kim, T M ; Cosgriff, T ; Srimuninnimit, V ; Pittman, K ; Sabbatini, R ; Rha, S Y ; Flaig, T W ; Page, R D ; Beck, J T ; Cheung, F ; Yadav, S ; Patel, P ; Geoffrois, L ; Niolat, J ; Berkowitz, N ; Marker, M ; Chen, D ; Motzer, R J

England: Oxford University Press

Texto completo disponible

Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J.J. ; Barrios, C.H. ; Kim, T.M. ; Cosgriff, T. ; Srimuninnimit, V. ; Pittman, K. ; Sabbatini, R. ; Rha, S.Y. ; Flaig, T.W. ; Page, R.D. ; Beck, J.T. ; Cheung, F. ; Yadav, S. ; Patel, P. ; Geoffrois, L. ; Niolat, J. ; Berkowitz, N. ; Marker, M. ; Chen, D. ; Motzer, R.J.

Elsevier Ltd

Texto completo disponible

Efficacy and safety data in elderly patients (pts) with metastatic renal cell carcinoma (mRCC) included in the nivolumab expanded access program (EAP) in Italy

Sabbatini, R. ; Galli, L. ; Pignata, S. ; Lo Re, G. ; Valcamonico, F. ; Defferrari, C. ; Spada, M. ; Santini, D. ; Masini, C. ; Ciuffreda, L. ; Ruggeri, E.M. ; Chioni, A. ; Livi, L. ; Fagnani, D. ; Bonetti, A. ; Giustini, L. ; Duranti, S. ; Procopio, G. ; Caserta, C. ; Cartenì, G.

Elsevier Ltd

Texto completo disponible

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J.J. ; Barrios, C.H. ; Kim, T.M. ; Cosgriff, T. ; Srimuninnimit, V. ; Pittman, K. ; Sabbatini, R. ; Rha, S.Y. ; Flaig, T.W. ; Page, R.D. ; Beck, J.T. ; Cheung, F. ; Yadav, S. ; Patel, P. ; Geoffrois, L. ; Niolat, J. ; Berkowitz, N. ; Marker, M. ; Chen, D. ; Motzer, R.J.

England: Elsevier Ltd

Texto completo disponible

Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

Caffo, O. ; Biasco, E. ; Facchini, G. ; Fratino, L. ; Gasparro, D. ; Mosillo, C. ; Basso, U. ; Santini, D. ; Tucci, M. ; Ortega, C. ; Verderame, F. ; Scagliarini, S. ; Re, G.L.o. ; Procopio, G. ; Fornarini, G. ; Campadelli, E. ; Sabbatini, R. ; Maines, F. ; De Giorgi, U.

Elsevier Ltd

Texto completo disponible

Clinical outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequences in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

Caffo, O. ; Biasco, E. ; Facchini, G. ; Fratino, L. ; Gasparro, D. ; Mosillo, C. ; Maruzzo, M. ; Santini, D. ; Tucci, M. ; Ortega, C. ; Verderame, F. ; Scagliarini, S. ; Lo Re, G. ; Procopio, G. ; Fornarini, G. ; Campadelli, E. ; Sabbatini, R. ; Maines, F. ; De Giorgi, U.

Texto completo disponible

Retrospective observational study of Vinflunine (VFL) in patients (pts) with transitional cell carcinoma of the urothelial tract (TCCU): final results of a real world population study (MOVIE-GOIRC01/2014 trial)

Passalacqua, R. ; Lazzarelli, S. ; Montironi, R. ; Pignata, S. ; De Giorgi, U. ; Bernardo, A. ; Ceresoli, G.L. ; Delconte, G. ; Donini, M. ; Iezzi, E. ; Maiello, E. ; Nolè, F. ; Panni, S. ; Perrucci, B. ; Rondini, E. ; Sabbatini, R. ; Sequino, M. ; Tonini, G. ; Zucali, P. ; Caminiti, C.

Texto completo disponible

Outcome of patients with multiple glandular metastases from renal cell carcinoma treated with targeted agents

Grassi, P. ; Grunwald, V. ; Melichar, B. ; Galli, L. ; De Giorgi, U. ; Sabbatini, R. ; Ortega, C. ; Santoni, M. ; Derosa, L. ; Porcu, L. ; Ratta, R. ; Mennitto, A. ; Verzoni, E. ; de Braud, F. ; Porta, C. ; Escudier, B. ; Procopio, G.

Texto completo disponible

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

Lorusso, D. ; Scambia, G. ; Pignata, S. ; Sorio, R. ; Amadio, G. ; Lepori, S. ; Mosconi, A. ; Pisano, C. ; Mangili, G. ; Maltese, G. ; Sabbatini, R. ; Artioli, G. ; Gamucci, T. ; Di Napoli, M. ; Capoluongo, E. ; Ludovini, V. ; Raspagliesi, F. ; Ferrandina, G.

England: Elsevier Ltd

Texto completo disponible

Effectiveness and possible molecular factors predictive of clinical outcomes in patients with transitional cell carcinoma of the urothelial tract (TCCU) treated with VInfluninE: a multicenter retrospective study (MOVIE) of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

Donini, M. ; Passalacqua, R. ; Montironi, R. ; Lazzarelli, S. ; Perrucci, B. ; Nole', F. ; Ceresoli, G.L. ; Pignata, S. ; Torriccelli, F. ; Tonini, G. ; Doni, L. ; Bernardo, A. ; Marcomini, B. ; Necchi, A. ; Betri, E. ; Degiorgi, U. ; Sabbatini, R. ; Rondini, E. ; Maiello, E. ; Caminiti, C.

Texto completo disponible